Skip to main content
Log in

Emergency ambulatory outpatient management of immune-mediated hypophysitis

  • Commentary
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Immune-mediated hypophysitis is an important toxicity related to immune checkpoint inhibitors (ICI). Optimal management is associated with improved outcomes. It represents a wide spectrum of clinical presentations, and a proportion may be suitable for emergency ambulatory management.

Methods

Emergency ambulatory management of patients presenting with clinical features and findings consistent with ICI-induced hypophysitis was considered at a tertiary cancer/endocrinology hospital. Suitable patients were initially investigated and treated in accordance with the UK emergency management guidelines for ICI induced hypophysitis. After an initial observation period of 4 h, patients were discharged with oral hydrocortisone (20, 10, 10 mg).

Results

An initial cohort of 4 patients with emergency presentations of ICI-induced hypophysitis has been managed in an ambulatory fashion in the first 3 months. There were no 30-day readmissions.

Conclusion

Carefully selected emergency presentations with immune-mediated hypophysitis may be suitable for ambulatory management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Rivera D, Gallicchio L, Brown J et al (2017) Trends in adult cancer-related emergency department utilisation. JAMA Oncol 3(10):e172450

    Article  Google Scholar 

  2. Todd KH, Thomas CR Jr (2016) An inflection point in the evolution of oncologic emergency medicine. Ann Emerg Med 68(6):712–716

    Article  Google Scholar 

  3. Cooksley T, Rice T (2017) Emergency oncology: development, current position and future direction in the US and UK. Support Care Cancer 25(1):3–7

    Article  Google Scholar 

  4. Cooksley T, Marshall W, Ahn S et al (2020) Ambulatory emergency oncology: a key tenet of future emergency oncology care. Int J Clin Pract 74(1):e13436

    Article  Google Scholar 

  5. Lasserson DS, Harris C, Elias T, Bowen J, Clare S (2018) What is the evidence base for ambulatory care for acute medical illness? Acute Med 17(3):148–153

    CAS  PubMed  Google Scholar 

  6. Haanen J, Carbonnel F, Robert C et al (2017) Management of toxicities from immunotherapy: ESMO clinical practice guidelines for diagnosis, treatment and follow up. Ann Oncol 28:iv119–iv142

    Article  CAS  Google Scholar 

  7. Knight T, Ahn S, Rice TW, Cooksley T (2017) Acute oncology care: a narrative review of the acute management of neutropenic sepsis and immune-related toxicities of checkpoint inhibitors. Eur J Intern Med 45:59–65

    Article  CAS  Google Scholar 

  8. Girotra M, Hansen A, Farooki A et al (2018) The current understanding of the endocrine effects from immune checkpoint inhibitors and recommendations for management. JNCI Cancer Spectr 2(3):21

    Article  Google Scholar 

  9. Champiat S, Lambotte O, Barreau E, Belkhir R, Berdelou A, Carbonnel F, Cauquil C, Chanson P, Collins M, Durrbach A, Ederhy S, Feuillet S, François H, Lazarovici J, le Pavec J, de Martin E, Mateus C, Michot JM, Samuel D, Soria JC, Robert C, Eggermont A, Marabelle A (2016) Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper. Ann Oncol 27:559–574

    Article  CAS  Google Scholar 

  10. Chang LS, Barroso-Sousa R, Tolaney S et al (2019) Endocrine toxicity of cancer immunotherapy targeting immune checkpoints. Endocr Rev 40(1):17–65

    Article  Google Scholar 

  11. Higham CE, Olsson-Brown A, Carroll P, Cooksley T, Larkin J, Lorigan P, Morganstein D, Trainer PJ (2018) Society for endocrinology endocrine emergency guidance: acute management of the endocrine complications of checkpoint inhibitor therapy. Endocr Connect 7(7):G1–G7

    Article  CAS  Google Scholar 

  12. Faje A, Lawrence D, Flaherty K et al (2018) High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma. Cancer 124(18):3706–3714

    Article  CAS  Google Scholar 

  13. Cooksley T, Gupta A, Al-Sayed T, Lorigan P (2020) Emergency presentations in patients treated with immune checkpoint inhibitors. Eur J Cancer 130:193–197

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tim Cooksley.

Ethics declarations

Disclosures

None

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cooksley, T., Knight, T., Gupta, A. et al. Emergency ambulatory outpatient management of immune-mediated hypophysitis. Support Care Cancer 28, 3995–3999 (2020). https://doi.org/10.1007/s00520-020-05581-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-020-05581-z

Keywords

Navigation